Nourish Raises $100M Series C for AI-Native Metabolic Health Clinic
Nourish, an AI-native healthcare platform focused on reversing chronic disease through metabolic health, has raised $100 million in a Series C round led by Menlo Ventures, with participation from Thrive Capital.
FUNDRAISE
Editor
5/21/20261 min read
Nourish has closed a $100 million Series C funding round, with capital earmarked to expand its AI-native metabolic health clinic. The round was led by Menlo Ventures, with participation from Thrive Capital — two of Silicon Valley's most recognised institutional investors.
Nourish operates as an AI-driven healthcare platform focused on reversing chronic disease through metabolic health interventions. The platform functions as a virtual clinic, connecting patients with personalised care programmes designed to address conditions tied to metabolic dysfunction, including obesity, insulin resistance, and related hormonal disorders.
The round was led by Menlo Ventures — known for investments in health and consumer technology — with Thrive Capital also participating. The $100 million raise will be used to expand Nourish's AI-driven clinical infrastructure and accelerate patient access across its programmes. The funding represents one of the largest raises in digital metabolic health to date.
Metabolic dysfunction sits at the intersection of several core men's health conditions: low testosterone, weight gain, cardiovascular risk, and erectile dysfunction are all closely linked to metabolic status. AI-native clinics that move beyond symptom management toward root-cause reversal represent a structural shift in how these conditions are addressed. The scale of investor confidence — Menlo and Thrive are both tier-one — confirms that metabolic health is now viewed as foundational digital health infrastructure, not a niche category.